rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-2-9
|
pubmed:abstractText |
To evaluate the safety, visual acuity changes, and morphologic effects associated with intravitreal bevacizumab injections for the management of macular edema due to ischemic central or hemicentral retinal vein occlusion (RVO).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0275-004X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
141-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17290194-Aged,
pubmed-meshheading:17290194-Angiogenesis Inhibitors,
pubmed-meshheading:17290194-Antibodies, Monoclonal,
pubmed-meshheading:17290194-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:17290194-Female,
pubmed-meshheading:17290194-Fluorescein Angiography,
pubmed-meshheading:17290194-Humans,
pubmed-meshheading:17290194-Injections,
pubmed-meshheading:17290194-Macular Edema,
pubmed-meshheading:17290194-Male,
pubmed-meshheading:17290194-Middle Aged,
pubmed-meshheading:17290194-Prospective Studies,
pubmed-meshheading:17290194-Retinal Vein Occlusion,
pubmed-meshheading:17290194-Tomography, Optical Coherence,
pubmed-meshheading:17290194-Vascular Endothelial Growth Factor A,
pubmed-meshheading:17290194-Visual Acuity,
pubmed-meshheading:17290194-Vitreous Body
|
pubmed:year |
2007
|
pubmed:articleTitle |
Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
|
pubmed:affiliation |
U.D.A.T.--Macular Imaging aaaa Treatment Division, Hospital de Olhos de Araraquara, Araraquara, São Paulo, Brazil. roger.retina@globo.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|